Recent Updates
Recently added Catalysts
OM Positive Sentiment Score: 75/100

Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Key Takeaway: Outset Medical, Inc. will announce its second quarter 2026 financial results on August 6, 2026. Following the release, CEO Leslie Trigg and CFO Renee Gaeta will host a conference call to discuss the results. The company is known for its innovative Tablo® Hemodialysis System, which simplifies dialysis processes.

Market Sentiment Analysis

POSITIVE FACTORS

  • Outset Medical is pioneering innovative technology for dialysis.
  • The company is expanding its reach with the Tablo® Hemodialysis System.
  • More than 1,000 U.S. healthcare facilities trust Outset's technology.

Full Press Release Details

SAN JOSE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter 2026 after the close of trading on Thursday, August 6, 2026.
On the same day, at 1:30 p.m. PT (4:30 p.m. ET), Leslie Trigg, Chair and Chief Executive Officer, and Renee Gaeta, Chief Financial Officer, will host a conference call to discuss the results.

Conference Call Details

Those interested in accessing the live or archived version of the conference call can visit the “Investors” section of the Outset Medical website athttps://investors.outsetmedical.com. Those interested in participating in the call via telephone may register online atthis link. Once registered, participants will receive a dial-in number and unique PIN to join the call. Participants are encouraged to register more than 15 minutes before the start of the call.
About Outset Medical, Inc.Outset is a medical technology company transforming the dialysis experience across the continuum of care with a first-of-its-kind technology. The Tablo®Hemodialysis System, FDA-cleared for use from hospital to home, is trusted by more than 1,000 U.S. healthcare facilities and has enabled millions of treatments delivered by thousands of nurses. Designed to reduce the cost and complexity of dialysis, Tablo combines water purification and on-demand dialysate production into a single, integrated system that connects seamlessly with Electronic Medical Record systems and a proprietary data analytics platform. This enterprise solution empowers providers to develop an in-house dialysis program where they are in control – enabling better operational, clinical, and financial outcomes. Outset is redefining what’s possible in kidney care through innovation, scale, and a relentless commitment to improving the lives of patients and the professionals who care for them. For more information, visitwww.outsetmedical.com.

Frequently Asked Questions

When will Outset Medical report its Q2 2026 results?

Outset Medical will report its Q2 2026 financial results on August 6, 2026.

Who will host the conference call for Q2 results?

Leslie Trigg, CEO, and Renee Gaeta, CFO, will host the conference call.

How can I access the conference call?

You can access the call via the Investors section on Outset's website.

What is the Tablo® Hemodialysis System?

The Tablo® Hemodialysis System is an innovative technology for dialysis care.

Last updated: Jul 23, 2026